Newsfeeds - Spark Newswire

1 minute read

Renalytix AI Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $619.00K Beat $610.00K Estimate

Today, 1:12 PM

Renalytix AI (NASDAQ:RNLX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. The company reported quarterly sales of $619.00 thousand which beat the

RNLX

1 minute read

Earnings Scheduled For June 15, 2021

By Benzinga Insights

Today, 1:12 PM

Companies Reporting Before The Bell • Qudian (NYSE:QD) is expected to report quarterly earnings at $0.29 per share on revenue of $95.97 million.

ATEX

2 minute read

Kantaro’s Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order. BZ NOTE: Kantaro Is A Joint Venture Between Mount Sinai Health System, RenalytixAI And Bio-Techne

By Benzinga Newsdesk

Today, 1:12 PM

Kantaro Biosciences, LLC (Kantaro), a joint venture between the Mount Sinai Health System and RenalytixAI (NASDAQ:RNLX), and its commercial partner Bio-Techne Corporation (NASDAQ:TECH), have received Health Canada

RNLX

5 minute read

Uncategorized

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal

By Shanthi Rexaline

Today, 1:12 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24)

ADVM

3 minute read

Uncategorized

Mid-Afternoon Market Update: Dow Falls 300 Points; Teradata Shares Spike Higher

By Lisa Levin

Today, 1:12 PM

Toward the end of trading Thursday, the Dow traded down 0.89% to 33,834 while the NASDAQ fell 0.71% to 13,850. The S&P also fell, dropping 0.76% to 4,141.60.

AENZ

1 minute read

Uncategorized

Renalytix AI Stock Jumps After 10-Year US Government Contract For Kidney Disease Testing Services

By Vandana Singh

Today, 1:12 PM

Renalytix AI plc (NASDAQ: RNLX) stock is rising on the heels of a 10-year contract from the United States Government to provide…

RNLX

Latest news

Renalytix AI Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $619.00K Beat $610.00K Estimate

Earnings Scheduled For June 15, 2021

Kantaro’s Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order. BZ NOTE: Kantaro Is A Joint Venture Between Mount Sinai Health System, RenalytixAI And Bio-Techne

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal

Mid-Afternoon Market Update: Dow Falls 300 Points; Teradata Shares Spike Higher

Renalytix AI Stock Jumps After 10-Year US Government Contract For Kidney Disease Testing Services